QUOTE AND NEWS
Marketwire  Nov 16  Comment 
LEIDEN, NETHERLANDS -- (Marketwire) -- 11/16/09 -- Global biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL) (SWISS: CRX) today announced the launch of the global Crucell brand, a consistent identity for its worldwide activities and
newratings.com  Nov 6  Comment 
NEW YORK, November 5 (newratings.com) - Analysts at UBS upgrade Crucell N.V. (ticker: CRXL) from "neutral" to "buy." [more]
StreetInsider.com  Nov 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/TapImmune+%28TPIV%29+In+License+Agreement+with+Crucell+%28CRXL%29/5078405.html for the full story.
StreetInsider.com  Nov 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/UBS+Upgrades+Crucell+NV+%28CRXL%29+to+Buy+/5078303.html for the full story.
StreetInsider.com  Nov 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Crucell+NV+%28CRXL%29+Posts+Q3+EPS+of+%E2%82%AC%240.15%2C+In-Line+with+Street%3B+Reiterates+Guidance/5067667.html for the full story.
Marketwire  Nov 3  Comment 
SAN DIEGO, CA -- (Marketwire) -- 11/03/09 -- Calmune Corporation, a privately held biotechnology company developing novel antibodies to address unmet clinical needs, announced today that it has established an exclusive research collaboration with
Marketwire  Nov 3  Comment 
LEIDEN, NETHERLANDS -- (Marketwire) -- 11/03/09 -- Total revenues and other operating income increased by 15% to EUR 94.3 million. Operating profit of EUR 15.5 million versus EUR 9.6 million in Q3 2008. Quarter-end cash and short-term liquidities of
Marketwire  Oct 27  Comment 
LEIDEN, NETHERLANDS -- (Marketwire) -- 10/27/09 -- Dutch biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL) (SWISS: CRX) today announced that it will release its financial results for the third quarter 2009 on Tuesday November 3, 2009 at
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
CRXL AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki